Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?
- P. Ranganathan
- , S. Eisen
- , W. M. Yokoyama
- , H. L. McLeod
- Division of Rheumatology
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Division of Veterans Affairs
- Bursky Center for Human Immunology and Immunotherapy
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
Research output: Contribution to journal › Review article › peer-review
66
Link opens in a new tab
Scopus
citations